MetLife Investment Management, LLC
Position in VRDN — Viridian Therapeutics, Inc.DE
CIK 1529735
Whippany, NJ
Position in VRDN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,858,788
+$12,489,975 QoQ
Shares Held
708,527
+1510.8% QoQ
Ownership
0.687%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 93.80277674668714.ToString("F0")%
Shared 0.ToString("F0")%
None 6.197223253312859.ToString("F0")%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. VRDN ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
This page
|
708,527 | $13,858,788 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,858,788 | 708,527 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,368,813 | 43,985 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $941,513 | 43,629 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $609,933 | 43,629 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $588,118 | 43,629 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $849,135 | 44,295 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $827,667 | 36,381 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $473,316 | 36,381 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $447,730 | 25,570 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $485,062 | 22,271 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $341,637 | 22,271 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $529,827 | 22,271 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $504,805 | 19,843 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $579,614 | 19,843 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $281,274 | 13,714 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $158,670 | 13,714 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||